Bromocriptine Mesylate (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Bromocriptine Mesylate drug offered from Mylan Pharmaceuticals Inc.. This Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | bromocriptine mesylate |
SUBSTANCE NAME: | BROMOCRIPTINE MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-06-17 |
END MARKETING DATE: | 0000-00-00 |
Bromocriptine Mesylate HUMAN PRESCRIPTION DRUG Details:
Item Description | Bromocriptine Mesylate from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2013-06-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-7096_4af5d2ca-f09e-4311-9db9-a9457d8bf01b |
PRODUCT NDC: | 0378-7096 |
APPLICATION NUMBER: | ANDA077226 |
Other BROMOCRIPTINE MESYLATE Pharmaceutical Manufacturers / Labelers: